Document Detail

The role of mitochondrial-mediated apoptosis in a myelodysplastic syndrome secondary to congenital deletion of the short arm of chromosome 4.
MedLine Citation:
PMID:  12644018     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Myelodysplastic syndromes (MDS) are characterized by peripheral cytopenia and ineffective hematopoiesis. In adult-onset MDS and in certain inherited marrow failure syndromes, apoptosis is increased and is mediated mainly through activation of the Fas pathway. It is unclear whether the various myelodysplastic disorders share the same apoptosis pathways. I investigated apoptosis pathways in a patient with refractory cytopenia with ring sideroblasts associated with congenital 4p deletion to determine the mechanism for bone marrow failure. METHODS: Marrow cells and lymphoblast cell lines generated from peripheral blood were analyzed for apoptosis and protein expression by flow cytometry, Western blot, and confocal microscopy, either directly or after gamma irradiation (15 G). Cell viability after treatment with inhibitors of specific apoptosis pathways was also determined. RESULTS: Compared to controls, the patient's marrow and lymphoblastoid cells showed significantly higher apoptosis rates and activation of caspase-3. Investigation of the mitochondrial apoptosis pathway showed a consistent pro-apoptosis profile, namely, upregulation of Bax, Bax-alpha, cytochrome c, and Apaf1, and low bcl-2. Differences between the patient's and the normal cells were further accentuated after irradiation; p53 expression was strikingly higher in the patient only after irradiation. In contrast, Fas and FADD expression on the patient's and the control's cells were comparable. Addition of caspase 3 or caspase 9 inhibitors markedly increased patient cell viablity, but blocking anti-Fas antibody did not. CONCLUSION: The ineffective hematopoiesis in this case is explained by increased apoptosis and is linked to hyperactivation of the mitochondrial cell death machinery and not to the Fas pathway, which might be secondary to an intramitochondrial defect. This information is crucial because the development of anti-apoptotic agents for the treatment of MDS may not be universally efficacious and should target the specific derangement.
Yigal Dror
Related Documents :
9366408 - Bcl-x protects primary b cells against fas-mediated apoptosis.
12893848 - Antisense oligonucleotide inhibition of bcl-xl and bid expression in liver regulates re...
10615948 - Nitric oxide production and fas surface expression mediate two independent pathways of ...
15013668 - Enhancement of fas-mediated apoptosis in ageing human keratinocytes.
24808358 - Caspase-8 acts as a molecular rheostat to limit ripk1- and myd88-mediated dendritic cel...
22031818 - Secreted osteopontin is highly polymerized in human airways and fragmented in asthmatic...
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Experimental hematology     Volume:  31     ISSN:  0301-472X     ISO Abbreviation:  Exp. Hematol.     Publication Date:  2003 Mar 
Date Detail:
Created Date:  2003-03-19     Completed Date:  2003-05-09     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0402313     Medline TA:  Exp Hematol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  211-7     Citation Subset:  IM    
Copyright Information:
Copyright 2003 International Society for Experimental Hematology
The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Apoptosis* / radiation effects
Case-Control Studies
Caspase 3
Caspases / metabolism
Child, Preschool
Chromosome Deletion*
Chromosomes, Human, Pair 4*
Leukocytes, Mononuclear / cytology,  radiation effects,  ultrastructure
Mitochondria / enzymology,  physiology*
Mitochondrial Proteins / biosynthesis,  metabolism,  radiation effects
Myelodysplastic Syndromes / etiology,  genetics,  pathology*
Up-Regulation / radiation effects
Reg. No./Substance:
0/Mitochondrial Proteins; EC 3.4.22.-/CASP3 protein, human; EC 3.4.22.-/Caspase 3; EC 3.4.22.-/Caspases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Genomic p16 abnormalities in the progression of chronic myeloid leukemia into blast crisis: a sequen...
Next Document:  Cycling B-CLL cells are highly susceptible to inhibition of the proteasome: involvement of p27, earl...